Phathom Pharmaceuticals Q1 2024 GAAP EPS $(1.42) Misses $(1.28) Estimate, Sales $1.912M Miss $2.047M Estimate
Phathom Pharmaceuticals Q1 2024 GAAP EPS $(1.42) Misses $(1.28) Estimate, Sales $1.912M Miss $2.047M Estimate
Phathom Pharmicals 2024年第一季度GAAP每股收益美元（1.42）未达到预期（1.28）美元，销售额19.12万美元低于20.47万美元的预期
Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(1.42) per share which missed the analyst consensus estimate of $(1.28) by 10.94 percent. This is a 59.55 percent decrease over losses of $(0.89) per share from the same period last year. The company reported quarterly sales of $1.912 million which missed the analyst consensus estimate of $2.047 million by 6.61 percent.
Phathom Pharmicals（纳斯达克股票代码：PHAT）公布的季度亏损为每股1.42美元，比分析师普遍预期的1.28美元（1.28美元）低10.94％。与去年同期每股亏损0.89美元（0.89）相比，下降了59.55％。该公司公布的季度销售额为19.12万美元，比分析师普遍预期的20.47万美元低6.61％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。